SOR-101

N/A

Report date: 2024/06/18 17:34:45

Base Information

Drug NameSOR-101
Drug Alias NameSOR-101SOR101
ClassificationBiologics
Mechanisms of ActionAnti-Tumor necrosis factor α
TargetsTumor necrosis factor α
Therapy Area/IndicationsColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSorriso Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsColitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A